Artisan Partners
ASND icon

Artisan Partners’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$689M Sell
3,990,424
-266,203
-6% -$45.9M 1.01% 29
2025
Q1
$663M Sell
4,256,627
-193,793
-4% -$30.2M 1.07% 23
2024
Q4
$613M Buy
4,450,420
+39,309
+0.9% +$5.41M 0.92% 27
2024
Q3
$659M Buy
4,411,111
+116,082
+3% +$17.3M 0.98% 26
2024
Q2
$586M Sell
4,295,029
-1,376,905
-24% -$188M 0.88% 35
2024
Q1
$857M Sell
5,671,934
-77,293
-1% -$11.7M 1.24% 24
2023
Q4
$724M Sell
5,749,227
-246,181
-4% -$31M 1.11% 24
2023
Q3
$561M Sell
5,995,408
-227,043
-4% -$21.3M 0.95% 28
2023
Q2
$555M Sell
6,222,451
-622,290
-9% -$55.5M 0.89% 34
2023
Q1
$734M Sell
6,844,741
-75,615
-1% -$8.11M 1.21% 21
2022
Q4
$845M Sell
6,920,356
-229,137
-3% -$28M 1.49% 13
2022
Q3
$738M Sell
7,149,493
-323,593
-4% -$33.4M 1.3% 17
2022
Q2
$695M Sell
7,473,086
-739,852
-9% -$68.8M 1.17% 20
2022
Q1
$964M Buy
8,212,938
+272,504
+3% +$32M 1.27% 17
2021
Q4
$1.07B Buy
7,940,434
+155,574
+2% +$20.9M 1.27% 16
2021
Q3
$1.24B Buy
7,784,860
+1,355,453
+21% +$216M 1.51% 8
2021
Q2
$846M Buy
6,429,407
+382,517
+6% +$50.3M 1.01% 29
2021
Q1
$779M Buy
6,046,890
+279,363
+5% +$36M 0.99% 31
2020
Q4
$962M Buy
5,767,527
+152,310
+3% +$25.4M 1.17% 14
2020
Q3
$867M Buy
5,615,217
+1,583,713
+39% +$244M 1.22% 16
2020
Q2
$596M Buy
4,031,504
+1,472,148
+58% +$218M 0.96% 29
2020
Q1
$288M Buy
2,559,356
+402,960
+19% +$45.4M 0.62% 52
2019
Q4
$300M Buy
2,156,396
+16,731
+0.8% +$2.33M 0.53% 58
2019
Q3
$206M Buy
2,139,665
+546,398
+34% +$52.6M 0.39% 67
2019
Q2
$183M Buy
1,593,267
+462,160
+41% +$53.2M 0.34% 73
2019
Q1
$133M Buy
1,131,107
+764,160
+208% +$89.9M 0.26% 79
2018
Q4
$23M Buy
366,947
+135,275
+58% +$8.47M 0.05% 209
2018
Q3
$16.4M Buy
231,672
+144,561
+166% +$10.2M 0.03% 218
2018
Q2
$5.8M Buy
+87,111
New +$5.8M 0.01% 242